Intellia Therapeutics (NTLA) R&D US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D, bln rub | 108.4 | 150.4 | 229.8 | 420.0 | 435.1 | 447.3 | |||
Changes by years, y/y, % | +22% | +39% | +53% | +83% | +4% | +37.3% |
Intellia Therapeutics. R&D, bln rub
Intellia Therapeutics. R&D, changes, %
Intellia Therapeutics. R&D, sum by quarters, bln rub
Intellia Therapeutics (NTLA) R&D US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
R&D, bln rub | 97.1 | 115.3 | 113.7 | 109.0 | 109.3 | 447.3 | ||
Changes by years, y/y, % | -27% | +28% | +18% | +9% | +13% | |||
Changes by quarters, q/q, % | -3% | +19% | -1% | -4% | +0% |